The first evidence for a role of BDNF in AN came from Nakazato et al. [18], who reported significantly lower serum BDNF levels in a small sample of individuals (aged 14–34 years) with acute AN (acAN) compared to both healthy comparison participants (HC) and individuals with bulimia nervosa (BN). The gene discussed is BDNF; the disease is bulimia nervosa.